Topics:
Atrial Fibrillation
Current versions available to download
Current translated versions available to download:
Authors
Valentin Fuster FESC, Co-Chair; Lars E. Ryden FESC, Co-Chair; David S. Cannom, Harry J. Crijns FESC, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey FESC, G. Neal Kay, James E. Lowe, S. Bertil Olsson FESC, Eric N. Prystowsky, Juan Luis Tamargo FESC, Samuel Wann FESC
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Definition
|
Atrial fibrillation, Related arrhythmias
|
Epidemiology and prognosis
|
Prevalence, Incidence, Prognosis |
Pathophysiological mechanisms
|
|
Causes, associated conditions, clinical manifestations, and quality of life
|
Clinical evaluation
|
|
Management
|
Pharmacological and nonpharmacological therapeutic options:
- Pharmacological therapy
- Heart rate control versus rhythm control
- Rate control during atrial fibrillation
- Preventing thromboembolism
- Cardioversion of atrial fibrillation
- Pharmacological agents to maintain sinus rhythm
- Out-of-hospital initiation of antiarrhythmic drugs in patients with atrial fibrillation
- Drugs under development
Direct-current cardioversion of atrial fibrillation and flutter:
- Terminology
- Technical aspects
- Procedural aspects
- Direct-current cardioversion in patients with implanted pacemakers and defibrillators
- Risks and complications of directcurrent cardioversion of atrial fibrillation
- Pharmacological enhancement of direct-current cardioversion
- Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion
Maintenance of sinus rhythm:
- Pharmacological therapy
- General approach to antiarrhythmic drug therapy
- Selection of antiarrhythmic agents in patients with cardiac diseases
- Nonpharmacological therapy for atrial fibrillation
- Suppression of atrial fibrillation through pacing
Special considerations:
- Postoperative AF
- Acute myocardial infarction
- Wolff-Parkinson-White (WPW) preexcitation syndromes
- Hyperthyroidism
- Pregnancy
- Hypertrophic cardiomyopathy
- Pulmonary diseases
- Primary prevention
|
Proposed management strategies
|
Overview of algorithms for management of patients with atrial fibrillation:
- Newly discovered atrial fibrillation
- Recurrent paroxysmal atrial fibrillation
- Recurrent persistent atrial fibrillation
- Permanent atrial fibrillation
|
Previous versions
2006: Corrigendum to ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:
Full Text | Executive Summary
2001:Euro Heart Journal 2001; 22, 1852–1923: Atrial Fibrillation (Management of):
Full text | Executive Summary
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here